Highest-materiality recent filing
Altria sets CEO Mancuso's pay at $1.35M base; Gifford to consult at $250K/month
New CEO Salvatore Mancuso receives $1.35M annual base salary, 40,634 RSUs and 37,246 PSUs vesting May 2031.
Altria Q1 adj. EPS $1.32 (+7.3% YoY), reaffirms FY guidance $5.56-$5.72
Q1 adjusted diluted EPS $1.32 vs $1.23 (+7.3%); reported EPS $1.30.
Altria reports FY 2025 adjusted EPS up 4.4%; guides FY 2026 adjusted EPS $5.56-$5.72
Full-year 2025 adjusted diluted EPS $5.42, up 4.4% YoY; reported EPS $4.12, down 37% on special items.
Altria FY2025 EPS $4.12, down 37%; records $1.2B goodwill impairment, $978M asset charges
Net revenues $23,279M, down 3% from $24,018M; gross profit $14,542M, up from $14,367M.
Altria CEO Billy Gifford to retire May 2026; Sal Mancuso named successor, Heather Newman as CFO
CEO Billy Gifford to retire May 14, 2026 after 30+ years (5+ as CEO); will serve as consultant through at least end of 2026.
Altria Q3 adj EPS $1.45 (+3.6%); narrows FY guide to $5.37-$5.45; buyback expanded to $2B
Q3 adjusted EPS $1.45 (+3.6% YoY); revenue net of excise taxes $5.25B (-1.7%).
Altria director George Muñoz to retire after current term, won't seek re-election in May 2026
George Muñoz, director since 2004, will retire after completing current term; no re-election at May 14, 2026 annual meeting.
Altria issues $1.0B in notes: $500M at 4.500% due 2030, $500M at 5.250% due 2035
Issued $500M of 4.500% Notes due 2030 and $500M of 5.250% Notes due 2035 in public offering.
Altria Q2 adj EPS $1.44 beat; raises FY25 guidance to $5.35-$5.45
Adjusted Q2 EPS of $1.44, up 8.3% YoY; net revenues ex-taxes $5.29B (+0.2%).
Altria extends $3B revolver maturity by one year to October 2029
Extended $3.0 billion 5-year revolver from October 24, 2028 to October 24, 2029.
Altria announces blackout period for DPS Plans due to trustee transition
Blackout from July 10, 2025 (4:00 PM ET) through week of July 13, 2025.
Altria controller to retire; Katie F. Patterson named successor; shareholders approve equity plans
Steven D'Ambrosia to retire as VP and Controller effective July 31, 2025.
Altria Q1 adjusted EPS rises 6% to $1.23; records $873M e-vapor goodwill impairment
Reported diluted EPS $0.63 (down 47.9% YoY); adjusted diluted EPS $1.23 (up 6.0% YoY).
Altria issues $1B in senior notes ($500M 4.875% due 2028, $500M 5.625% due 2035)
Altria issued $500M of 4.875% notes due 2028 and $500M of 5.625% notes due 2035.
Altria posts FY2024 adj. EPS $5.12; ITC bans NJOY ACE; new $1B buyback
Full-year 2024 adjusted diluted EPS of $5.12, up 3.4% YoY; Q4 adjusted EPS $1.29, up 9.3%.
Altria reports 2024 net earnings $11.3B, EPS $6.54; dividend raised to $4.00
Net earnings $11.26B ($6.54 diluted EPS) vs $8.13B ($4.57) in 2023; net revenues $24.02B vs $24.48B.
Q3 adjusted diluted EPS $1.38 (+7.8% YoY); reported EPS $1.34 (+9.8%).
Altria Q2 adjusted EPS flat at $1.31; narrows FY2024 guidance to $5.07-$5.15
Q2 adjusted diluted EPS $1.31 (flat YoY); reported EPS $2.21 (up 85.7% on IQOS gain).
All 10 director nominees elected with strong support; each received over 1 billion votes for.
Altria Q1 2024 adjusted EPS $1.15 (-2.5% YoY); reaffirms FY guidance $5.05-$5.17
Reported diluted EPS $1.21 (up 21% YoY); adjusted diluted EPS $1.15 (down 2.5% YoY).
Altria sells 35M ABI shares, reduces stake to ~8.1%; launches $2.4B ASR
Sold 35M ABI ordinary shares (12.25M ADS at $59.9625/share; 22.75M ordinary at €54.76575/share) in secondary offering.
Altria sells $2.4B of ABI shares, boosts buyback by $2.4B, raises FY2024 EPS guidance
Sold 35M ABI shares at $61.50/ADS plus $200M direct ABI repurchase; total ~$2.4B.
Altria EVP & General Counsel Garnick to retire April 1; receives pro-rated equity conversion
Murray R. Garnick to retire as EVP and General Counsel effective April 1, 2024.
Altria director Jacinto J. Hernandez retires from board, stays as strategic advisor at $300k/year
Jacinto J. Hernandez retired from Altria's Board effective February 23, 2024.
Altria reports Q4 adj. EPS flat at $1.18; 2024 guidance $5.00-$5.15; GC retires
Q4 adjusted diluted EPS $1.18 (flat YoY); full-year adj. EPS $4.95 (+2.3%); Q4 net revenue $5,024M ex-taxes (-1.2%).
Altria reports FY2023 EPS of $4.57, up 43% YoY; revenue falls 2.4% to $24.5B
Net earnings $8.13B ($4.57 diluted EPS) vs $5.76B ($3.19) in 2022; operating income $11.55B down 3.1%.
Altria issues $1B in senior notes: $500M at 6.200% due 2028, $500M at 6.875% due 2033
Issued $500M 6.200% Notes due 2028 and $500M 6.875% Notes due 2033 on November 1, 2023.
Altria Q3 adjusted EPS flat at $1.28; narrows FY2023 guidance to $4.91-$4.98
Q3 reported EPS $1.22 vs $0.12 YoY (100%+); adjusted EPS unchanged at $1.28.
Altria enters new $3B revolving credit facility; director Sakkab to retire at 2024 meeting
New $3B 5-year revolving credit facility with JPMorgan and Citibank as agents, expiring Oct 2028, with two 1-year extension options.
Altria Board adopts annual say-on-pay votes following shareholder advisory vote
Board determined, after shareholder vote, future advisory votes on exec compensation will be held annually.
Altria Q2 adjusted EPS $1.31, up 4%; reaffirms FY2023 guidance
Q2 adjusted diluted EPS $1.31, up 4.0% YoY; reported EPS $1.19 vs $0.49.
Altria completes $2.75B NJOY acquisition; updates 2023 EPS guidance to $4.89-$5.03
Completed acquisition of NJOY for ~$2.75B cash; up to $500M additional contingent on FDA approvals for certain NJOY products.
Altria shareholders elect 12 directors, ratify PwC, approve say-on-pay, defeat two proposals
All 12 director nominees elected with votes ranging from 1.07B to 1.10B for; quorum 81.39% (1.454B shares).
Altria agrees to resolve 6,000+ JUUL cases for $235M, records Q2 charge
Settles at least 6,000 JUUL-related state and federal cases for $235M aggregate, including attorneys' fees.
Altria Q1 2023 adjusted EPS $1.18 (+5.4%); reaffirms FY guide $4.98-$5.13
Reported net revenues $5,719M (-2.9%); revenues net of excise taxes $4,763M (-1.2%).
Altria sets 2028 goals for mid-single digit EPS/dividend growth; reaffirms 2023 guidance
New 2028 Enterprise Goals: mid-single digits CAGR adjusted diluted EPS growth; progressive dividend policy targeting mid-single digits annual dividend growth.
Altria exchanges JUUL stake for IP license, agrees to acquire NJOY for $2.75B
Exchanged $250M JUUL investment for non-exclusive global license to JUUL's heated tobacco IP; Q1 2023 impact.
Altria Q4 adj EPS $1.18 (+8.3%); guides FY23 adj EPS $4.98-$5.13
Q4 adjusted diluted EPS $1.18, up 8.3% YoY; full-year adjusted EPS $4.84, up 5.0%.
Altria reports FY 2022 revenue $25.1B, net earnings $5.8B, EPS $3.19; equity losses $3.6B
FY 2022 net revenues $25.1B (down 3.5% YoY); operating income $11.9B (up 3.1%).
Court preliminarily approved settlement of shareholder derivative actions over Altria's $12.8B JUUL investment on Oct. 26, 2022.
Adjusted diluted EPS $1.28, up 4.9% YoY; net revenues $6.55B, down 3.5%.
Altria to assign IQOS U.S. rights to PMI for $2.7B cash, effective April 2024
Altria receives $1B immediately and $1.7B (plus 6% interest) by July 15, 2023 from PMI subsidiary Triaga.
Altria exercises option to exit JUUL non-compete; carrying value drops from $12.8B to $450M
Exercised option on Sept 29, 2022, permanently terminating non-competition obligations to JUUL.
Altria extends $3B credit facility maturity to 2025, transitions to Term SOFR
Maturity extended from Aug 1, 2024 to Aug 1, 2025.
Altria Q2 adj. EPS $1.26 (+2.4% YoY); reaffirms FY22 guidance; records $1.2B JUUL loss
Q2 reported EPS $0.49 (down 57.8%) due to $1.2B non-cash unrealized loss on JUUL investment; adjusted EPS $1.26 (up 2.4%).
All 12 director nominees elected; highest votes for R. Matt Davis (1.15B for) and lowest for George Muñoz (1.12B for).
Altria Q1 adj. EPS $1.12 (+4.7%YoY); reaffirms FY22 adj. EPS $4.79-$4.93
Reported net revenue $5.9B (-2.4%), down due to wine business sale; revenue net of excise taxes $4.8B (-1.3%).
Altria director Devitre retiring after current term; not standing for re-election at May 19 meeting
Devitre retiring from Altria board after current term; not standing for re-election at May 19, 2022 meeting.
Altria reports FY 2021 adjusted EPS $4.61 (+5.7%); guides FY 2022 adjusted EPS $4.79-$4.93
Q4 2021 adjusted diluted EPS $1.09 (+10.1% YoY); reported EPS $0.88 (-14.6% YoY) on ABI impairment.
Altria FY2021 net earnings down 44% to $2.48B; equity method losses of $5.98B
Net earnings $2.48B ($1.34 EPS) down 44% from $4.47B ($2.40 EPS) in 2020.
As previously reported, William F. Gifford, Jr. retired as Altria’s CEO effective upon the conclusion of the Annual Meeting.
As previously reported, Salvatore Mancuso was elected Chief Executive Officer (“CEO”) of Altria Group, Inc. (“Altria”) effective upon the conclusion of Altria’s Annual Meeting of Shareholders held on May 14, 2026
Also as previously reported, Heather A. Newman was elected Executive Vice President and Chief Financial Officer of Altria effective upon the conclusion of the Annual Meeting.
On May 13, 2025, Steven D’Ambrosia, Vice President and Controller of Altria Group, Inc. (“Altria”), announced his intention to retire as Vice President and Controller effective July 31, 2025.
On May 15, 2025, Altria’s Board of Directors (the “Board”) elected Katie F. Patterson to become Vice President and Controller of Altria, effective upon Mr. D’Ambrosia’s retirement.
elected Richard S. Stoddart to the Board, in each case, effective February 3, 2025.
As previously announced, Murray R. Garnick, Executive Vice President and General Counsel, of Altria Group, Inc. (“Altria”) announced his intention to retire effective April 1, 2024.
On February 23, 2024, Jacinto J. Hernandez, a director of Altria Group, Inc. (“Altria”), notified Altria of his decision to retire from service on its Board of Directors effective immediately.
On January 29, 2024, Murray R. Garnick, Altria’s Executive Vice President and General Counsel, announced his intention to retire effective April 1, 2024.
Nabil Y. Sakkab (age 76), a director of Altria since 2008, submitted his written resignation to the Board, and, on October 25, 2023, the Board, based on the recommendation of the Board’s Nominating, Corporate Governance and Social Responsibility Committee, accepted Dr. Sakkab’s resignation effective upon completion of his term.
W. Leo Kiely III (age 75), a director of Altria since 2011, submitted his written resignation to the Board, and, on October 26, 2022, the Board, based on the recommendation of the Board’s Nominating, Corporate Governance and Social Responsibility Committee, accepted Mr. Kiely’s resignation effective upon completion of his current term.
On October 26, 2022, the Board increased the size of the Board from 12 to 13 and elected Jacinto Hernandez to the Board, in each case, effective November 1, 2022.
Max materiality 0.85 · Median 0.72 · Most common event earnings